
Medcorpus Pharmaceuticals Private Limited
Manufactures and sells various pharmaceutical products for allopathic, homeopathic, unani, ayurvedic and other medical disciplines.
Manufactures and sells various pharmaceutical products for allopathic, homeopathic, unani, ayurvedic and other medical disciplines.
Medcorpus Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 September 2016 (Eight years and six months 9 days old ). Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Kannan Gurumurthy, Pragadeeswaran, and Thangaraj Subbiah serve as directors at the Company.
Tiruvallur, Tamil Nadu, India
+91-XXXXXXXXXX
U51909TN2016PTC112571
112571
Private Limited Indian Non-Government Company
19 Sep 2016
30 Sep 2024
31 Mar 2024
Unlisted
Roc Chennai
Medcorpus Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Nutritional Supplements, Respiratory System Drugs, Anti Asthma Drug, Digestive System Drugs & Medicines, Antacid Drugs, Common Disease Medicines, Antihistamines, Ayurvedic,Herbal Products & Medicine.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kannan Gurumurthy ![]() | Director | 19-Sep-2016 | Current |
Pragadeeswaran ![]() | Director | 19-Sep-2016 | Current |
Thangaraj Subbiah ![]() | Director | 19-Sep-2016 | Current |
Medcorpus Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 43.49% increase. The company also saw a substantial improvement in profitability, with a 131.77% increase in profit. The company's net worth Soared by an impressive increase of 15.38%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2018, Medcorpus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Medcorpus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medcorpus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medcorpus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Medcorpus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Medcorpus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Kannan Gurumurthy was appointed as a Director was appointed as a Director on 19 Sep 2016 & has been associated with this company since 8 years 6 months .
Pragadeeswaran was appointed as a Director was appointed as a Director on 19 Sep 2016 & has been associated with this company since 8 years 6 months .
Thangaraj Subbiah was appointed as a Director was appointed as a Director on 19 Sep 2016 & has been associated with this company since 8 years 6 months .
Medcorpus Pharmaceuticals Private Limited was registered on 19 Sep 2016 with Roc Chennai & aged 8 years 6 months as per MCA records.
Medcorpus Pharmaceuticals Private Limited was incorporated on 19 Sep 2016.
The authorized share capital of Medcorpus Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.15 M.
Currently 3 directors are associated with Medcorpus Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Medcorpus Pharmaceuticals Private Limited is No.1 (10) Ground Floor Jayaram Nagar 1St Main Road Nagar, India, Kolathur, Tamil Nadu, 600099.
The corporate identification number (CIN) of Medcorpus Pharmaceuticals Private Limited is U51909TN2016PTC112571 and the company number is 112571 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Medcorpus Pharmaceuticals Private Limited has risen by 43.49%.
The financial reports for the fiscal year 2022 indicates that The net worth of Medcorpus Pharmaceuticals Private Limited has experienced an upsurge of 15.38%.
The most recent Balance Sheet for Medcorpus Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.